Overall, the TNF-α/IGF2BP3/CLDN11 axis was involved in the mechanism of obesity-mediated SAP exacerbation and suggests potential therapeutic targets. The gene discussed is CLDN11; the disease is obesity due to melanocortin 4 receptor deficiency.